CliniQuantum Acquired by NeuroThera Labs — Healthcare M&A

NeuroThera Labs has acquired CliniQuantum, a healthcare services other business in the United States, for an undisclosed amount. CliniQuantum develops quantum-based clinical trials and related healthcare services, supporting innovation in patient research and treatment testing. NeuroThera Labs acquisitions focus on expanding clinical development capabilities through this CliniQuantum acquisition. The strategic acquisition is structured as an add on acquisition, with NeuroThera Labs taking a 75% majority stake as part of healthcare M&A. The deal is announced and based on a definitive agreement, with closing terms not disclosed.